Navigation Links
Study Shows Otamixaban Substantially Reduced Complications of Invasive Management of Acute Coronary Syndromes
Date:8/30/2009

st marketing, decisions by regulatory authorities, such as the FDA or the EMEA, regarding whether and when to approve any drug, device or biological application that may be filed for any such product candidates as well as their decisions regarding labelling and other matters that could affect the availability or commercial potential of such products candidates, the absence of guarantee that the products candidates if approved will be commercially successful, the future approval and commercial success of therapeutic alternatives as well as those discussed or identified in the public filings with the SEC and the AMF made by Sanofi-aventis, including those listed under "Risk Factors" and "Cautionary Statement Regarding Forward-Looking Statements" in Sanofi-aventis' annual report on Form 20-F for the year ended December 31, 2008. Other than as required by applicable law, Sanofi-aventis does not undertake any obligation to update or revise any forward-looking information or statements.


'/>"/>
SOURCE Sanofi-aventis
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. New Large-Scale, Global Study Provides Additional Information About an Intensified Dose-Regimen of PLAVIX(R) in Acute Coronary Syndrome Patients Undergoing Angioplasty
2. Gen-Probe Begins U.S. Clinical Study of PROGENSA(R) PCA3 Assay, New Molecular Test to Help Assess Prostate Cancer Risk
3. Lurasidone Demonstrated Efficacy in Treating Patients With Schizophrenia in Pivotal Phase 3 Study
4. Cardium Completes Initial Patient Evaluation Period for MATRIX Phase 2b Excellarate Clinical Study
5. CardioDx Completes Validation Study of First-Of-Its-Kind Genomic Test for Coronary Artery Disease
6. R-Tech Ueno Completes Subject Enrollment in Phase 2 Clinical Study of 0.15% UF-021
7. WorldHeart Receives US Clinical Study Approval for the Levacor(TM) VAD
8. Impax Pharmaceuticals Selects OmniComm Systems to Provide eClinical Solutions for International Phase III Study in Parkinsons Disease
9. Study Links Fetal Fibronectin Testing with Changes in Management Decisions for Symptomatic and Asymptomatic Women at Risk for Preterm Birth
10. Study of Lacrisert(R) Dry Eye Insert Published in The Ocular Surface
11. Amarex Clinical Research Selects OmniComm Systems to Provide eClinical Solutions for Phase III Medical Device Study and Joins OmniComms CRO Preferred Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/1/2015)... YORK , May 1, 2015  Shares of ... 70% of their value yesterday following the results of ... glaucoma therapy, Rhopressa.  Despite the trial failing to meet ... that positive results may come from future studies. ... brief company overview, current pipeline, financial review, analyst summary, ...
(Date:4/30/2015)... -- Omnicell, Inc. (NASDAQ: OMCL ), a leading provider ... today announced results for its first quarter ended March ... first quarter of 2015 was $116.2 million, up $14.5 ... and down $5.3 million or 4.4% from the fourth ... income as reported in accordance with U.S. generally accepted ...
(Date:4/30/2015)... April 30, 2015  Tandem Diabetes Care ® , Inc. ... of the t:slim ® and t:flex™ Insulin Pumps, today ... 2015. In comparing the first quarter of ... grew 53 percent to $12.3 million from $8.1 million ... from 1,723 pumps "Our investment in resources to ...
Breaking Medicine Technology:All is Not Lost for Aerie Pharmaceuticals - VLM Research Issued by BrokerBank Securities, Inc. 2Omnicell Announces First Quarter 2015 Results 2Omnicell Announces First Quarter 2015 Results 3Omnicell Announces First Quarter 2015 Results 4Omnicell Announces First Quarter 2015 Results 5Omnicell Announces First Quarter 2015 Results 6Omnicell Announces First Quarter 2015 Results 7Omnicell Announces First Quarter 2015 Results 8Omnicell Announces First Quarter 2015 Results 9Omnicell Announces First Quarter 2015 Results 10Omnicell Announces First Quarter 2015 Results 11Omnicell Announces First Quarter 2015 Results 12Omnicell Announces First Quarter 2015 Results 13Omnicell Announces First Quarter 2015 Results 14Omnicell Announces First Quarter 2015 Results 15Omnicell Announces First Quarter 2015 Results 16Omnicell Announces First Quarter 2015 Results 17Omnicell Announces First Quarter 2015 Results 18Omnicell Announces First Quarter 2015 Results 19Omnicell Announces First Quarter 2015 Results 20Omnicell Announces First Quarter 2015 Results 21Omnicell Announces First Quarter 2015 Results 22Omnicell Announces First Quarter 2015 Results 23Omnicell Announces First Quarter 2015 Results 24Omnicell Announces First Quarter 2015 Results 25Omnicell Announces First Quarter 2015 Results 26Omnicell Announces First Quarter 2015 Results 27Tandem Diabetes Care Reports First Quarter 2015 Financial Results 2Tandem Diabetes Care Reports First Quarter 2015 Financial Results 3Tandem Diabetes Care Reports First Quarter 2015 Financial Results 4Tandem Diabetes Care Reports First Quarter 2015 Financial Results 5Tandem Diabetes Care Reports First Quarter 2015 Financial Results 6
... The U.S. Food and Drug Administration today issued ... use needle-free clinical devices to administer influenza vaccinations. Based ... KR ) immediately discontinued use of such clinical devices ... The Kroger family of pharmacies and The ...
... Oct. 21, 2011 Robbins Umeda LLP, a ... into possible breaches of fiduciary duty and other violations ... KV Pharmaceutical Company (NYSE: KV-A, KV-B). ... investigation focuses on whether officials at KV Pharmaceuticals breached ...
Cached Medicine Technology:Robbins Umeda LLP Announces an Investigation of KV Pharmaceutical Company 2
(Date:5/1/2015)... Jusuru International has been awarded the ... of its flagship nutritional supplement, Liquid BioCell™ Life, and ... name, new logo, new packaging, new products, and new ... to identify and promote programs that serve as examples ... congratulates Jusuru International for their outstanding accomplishments and contributions ...
(Date:5/1/2015)... 01, 2015 The Workgroup for ... authority on the use of health IT to create ... contributing resource to the United States Government Accountability Office ... readable cards in Medicare. The report, “ Potential Uses ... was released to the public on Apr. 24, 2015 ...
(Date:5/1/2015)... 01, 2015 It’s raining bills on Capitol ... proposals to expand federal support for telemedicine. , ... has been working with Congress,” said Jonathan Linkous, CEO of ... the nation is poised to embrace the use of telecommunications ... step in fulfilling ATA’s mission to improve quality, access, equity ...
(Date:5/1/2015)... Ernst & Young (EY) has announced Melanie Rosenthal, ... and Burak Sezen, Co-Founder & CTO of RowdMap, Inc. ... The Year® 2015 Awards in the Ohio Valley Region ... leader in assurance, tax, transaction and advisory services and ... audit companies in the world. The awards program recognizes ...
(Date:5/1/2015)... The Quail Creek Relay for Life Team raised ... the Quail Creek Relay team has raised almost $860,000. ... year, including their biggest event, January’s Dinner and Auction; an ... Quail Creek Relay for Life team was established to honor ... director, states, “I was hooked when I learned how the ...
Breaking Medicine News(10 mins):Health News:Jusuru International Receives 2015 DSA Ethos Award 2Health News:Jusuru International Receives 2015 DSA Ethos Award 3Health News:Jusuru International Receives 2015 DSA Ethos Award 4Health News:Jusuru International Receives 2015 DSA Ethos Award 5Health News:WEDI Contributes to Newly Released U.S. Government Accountability Office (GAO) Study on Potential Use of Electronically Readable Medicare Cards 2Health News:WEDI Contributes to Newly Released U.S. Government Accountability Office (GAO) Study on Potential Use of Electronically Readable Medicare Cards 3Health News:ATA: Congress Floods the Halls with Telemedicine Proposals 2Health News:RowdMap, Inc. Named as a Ernst & Young Entrepreneur Of The Year® 2015 Award Finalist 2Health News:Quail Creek Country Club’s Relay for Life Team Raised Over $89,000 for American Cancer Society 2
... highly complementary businesses - ... - $12-14 million of expected annual ... earnings per share in 2009, LISLE, IL, and PORT ... or the "Company") (NASDAQ: SXCI, TSX:,SXC) and National Medical Health ...
... ... http://www.cryocath.com , MONTREAL, Feb. 26 /PRNewswire-FirstCall/ - CryoCath(R) ... announced that Chief Financial Officer, L. Derek,Lindsay, will be leaving the ... take over the role of Chief Financial Officer at,CryoCath. Mr. Lindsay ...
... TSX: BMR, TORONTO, Feb. 26 ... company dedicated to the development and,commercialization ... Phase II data,on the Company,s Neuradiab ... newly,diagnosed glioblastoma multiforme (GBM) were published ...
... Minn., Feb. 26 Construction is,underway to expand ... size of the six-year-old location. When completed in ... procedure rooms, improved privacy for,inpatients waiting for procedures ... $2.1 million project also will provide expanded space ...
... Carriage Services, Inc.,(NYSE: CSV ) today announced plans to ... 2008 after the market closes. In,conjunction with the release, Carriage ... over the Internet, for Friday, March 7,2008 at 10:00 a.m. ... 2007 Earnings Conference Call, When: Friday, March 7, ...
... Billion With a 14% Rise in Core ... Broadband Business Merger Paying Off: Q4 Gross Margin of 33% & ... ... Market and TASE: SMLC), a,growth-oriented provider of communication services in Israel, today,reported its financial results ...
Cached Medicine News:Health News:SXC Health Solutions Corp. to acquire National Medical Health Card Systems, Inc. 2Health News:SXC Health Solutions Corp. to acquire National Medical Health Card Systems, Inc. 3Health News:SXC Health Solutions Corp. to acquire National Medical Health Card Systems, Inc. 4Health News:SXC Health Solutions Corp. to acquire National Medical Health Card Systems, Inc. 5Health News:SXC Health Solutions Corp. to acquire National Medical Health Card Systems, Inc. 6Health News:SXC Health Solutions Corp. to acquire National Medical Health Card Systems, Inc. 7Health News:SXC Health Solutions Corp. to acquire National Medical Health Card Systems, Inc. 8Health News:CryoCath Appoints New Chief Financial Officer 2Health News:Bradmer announces Phase II results published in newly diagnosed glioblastoma which demonstrate improved survival and support upcoming Phase III study 2Health News:Bradmer announces Phase II results published in newly diagnosed glioblastoma which demonstrate improved survival and support upcoming Phase III study 3Health News:Bradmer announces Phase II results published in newly diagnosed glioblastoma which demonstrate improved survival and support upcoming Phase III study 4Health News:Expansion Will Double Size of The Heart Center at Regions Hospital 2Health News:Carriage Services Announces Fourth Quarter and Year-End Earnings Release and Conference Call Schedule 2Health News:012 Smile.Communications Reports Financial Results for Q4 and Full Year 2007 2Health News:012 Smile.Communications Reports Financial Results for Q4 and Full Year 2007 3Health News:012 Smile.Communications Reports Financial Results for Q4 and Full Year 2007 4Health News:012 Smile.Communications Reports Financial Results for Q4 and Full Year 2007 5Health News:012 Smile.Communications Reports Financial Results for Q4 and Full Year 2007 6Health News:012 Smile.Communications Reports Financial Results for Q4 and Full Year 2007 7Health News:012 Smile.Communications Reports Financial Results for Q4 and Full Year 2007 8Health News:012 Smile.Communications Reports Financial Results for Q4 and Full Year 2007 9Health News:012 Smile.Communications Reports Financial Results for Q4 and Full Year 2007 10Health News:012 Smile.Communications Reports Financial Results for Q4 and Full Year 2007 11Health News:012 Smile.Communications Reports Financial Results for Q4 and Full Year 2007 12
... Vision, Quality of Vision and Contrast ... target illumination and glare luminance levels ... Day/Night testing with/without glare and background ... all ANSI standards. All Light Levels ...
Contrast Sensitivity is Recognized as a Valuable Tool for Measuring Functional Vision Loss Caused by Early Eye Disease. Distance Test S.W.C.T. 201: Size 27in x 37 in (68.58cm x 93.98cm),Can be Wal...
Vectograms are the standard for vision training. They are available in fixed or variable,styles to accommodate unlimited base-in and base-out training. Each vectogram,includes one pair,of standard 3-...
Adult: Letter Monocular Acuity, Binocular Astigmatism, Acuity Balance, Supression, Binocular Acuity, Fixation Desparity, Muscle Balance, Stereopsis...
Medicine Products: